Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Shaers of Altria Group Inc. MO, -5.83% slipped 0.2% in premarket trading Thursday, after the cigarette and heated tobacco seller reported third-quarter profit that missed expectations while revenue fell but beat forecasts. Net losses widened to $2.7 billion, or $1.48 a share, from $952 million, or 51 cents a share, in the year-ago period.

Altria stock slips after adjusted profit misses expectations, while revenue beat

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA REPORTS 2021 THIRD-QUARTER AND NINE-MONTHS RESULTS; ANNOUNCES EXPANDED SHARE REPURCHASE PROGRAM; NARROWS 2021 FULL-YEAR EARNINGS GUIDANCE

Altria Reports 2021 Third-Quarter and Nine-Months Results; Announces Expanded Share Repurchase Program; Narrows 2021 Full-Year Earnings Guidance

RICHMOND, Va.--(BUSINESS WIRE)---- $MO #ALTRIA--ALTRIA ANNOUNCES ELECTION OF TWO BOARD MEMBERS AND RETIREMENT OF JOHN T. CASTEEN III

Altria Announces Election of Two Board Members and Retirement of John T. Casteen III

Amazon

British American Tobacco

Magellan Midstream Partners

NextEra Energy

The market is back to record highs, after a very mild 5.2% pullback that hid a rolling bear market that crushed many high-flying tech stocks by over 50%.

6 High-Yield Blue-Chips That Could Triple In The Next 5 Years

Hershey

JPMorgan Chase & Co

L3Harris

Schlumberger

It's an old term, so old that many younger investors may not even really know what it means.

5 Top Dividend Stocks to Buy Now Should Still Perform Well If Stagflation Bubbles Up

Franklin Resources

Cardinal Health

The short "taper tantrum 2.0" lasted a few weeks and saw stocks fall just 5.2%. We're now back to record highs and a 26% historically overvalued market. Fortunately, it will always be a market of stocks and not a stock market. At any given time, 40% of blue-chips are trading at fair value or better.

My, Oh My, 3 High-Yield Dividend Aristocrat Strong Buys

Altria Group's (MO) third-quarter results are likely to reflect gains from pricing and strength in reduced risk products.

Factors to Consider Before Altria Group's (MO) Q3 Earnings

In the latest trading session, Altria (MO) closed at $48.22, marking a -0.02% move from the previous day.

Altria (MO) Stock Moves -0.02%: What You Should Know

Bank of America

ConocoPhillips

Johnson & Johnson

Regions Financial

Worried about inflation that's turned out not to be so "transitory?" These seven safe stocks may be the place to be right now.

7 Safe Stocks to Own to Hedge Against Inflation

My worst ever timed investment was purchasing Altria in the middle of 2017, merely weeks before their share price plunged following the FDA proposal to lower nicotine in cigarettes. It has since felt like a continuous wave of negative headlines weighing down their share price, despite their financial performance remaining resilient and dividends growing almost 50% higher.

Altria: Share Price May Never Recover, But I'm Still Buying

Philip Morris

E-cigarette usage is sure to gain traction, particularly in light of the FDA's announcements in October. It just doesn't matter to the tobacco industry as we know it.

Vaping's Growth (Still) Can't Offset Smoking's Decline

Altria (MO) strives to expand IQOS and on! amid consumers' rising preference on low-risk tobacco alternatives.

Focus on Low-Risk Offerings Drives Altria (MO), Pricing Aids

RICHMOND, Va.--(BUSINESS WIRE)---- $MO--ALTRIA TO HOST WEBCAST OF 2021 THIRD-QUARTER RESULTS

Altria to Host Webcast of 2021 Third-Quarter Results

Turning Point Brands

Today, investors in vape stocks are seeing some positive price action following news that the FDA had approved e-cigarettes in the U.S. The post Vape Stocks: What's Going on With MO, BTI, TPB Stocks Today? appeared first on InvestorPlace.

Vape Stocks: What's Going on With MO, BTI, TPB Stocks Today?

The Food and Drug Administration approves an e-cigarette in the U.S. for the first time.

Vape Maker Stocks Are Mixed After FDA Approves an E-Cigarette

Diageo

Lockheed Martin

Constellation Brands

Vici Properties

Regardless of what happens these days, the market seems to push higher. Interest rates shooting up?

5 Dividend-Paying Sin Stocks to Buy May Survive a Massive Market Sell-Off

Leggett & Platt

Unilever

Having a steady stream of income is key to ensuring a worry-free retirement.

3 Stocks to Buy if You Want $1,000 a Month in Dividends

In the latest trading session, Altria (MO) closed at $46.71, marking a -0.04% move from the previous day.

Altria (MO) Stock Moves -0.04%: What You Should Know

The Zacks Tobacco industry gains from reduced-risk products and solid pricing. Such upsides have been benefiting companies like Philip Morris (PM), Altria (MO) and Turning Point Brands (TPB).

3 Tobacco Stocks to Watch Out For on RRPs and Pricing Gains

Target

Walmart

It's not often investors get opportunities to buy phenomenal growth stocks at a generous discount.

These 3 Growth Stocks Did Terribly in September, but Now Is the Time to Buy

The tobacco giant had been counting on the heated tobacco device for future growth.

Is the IQOS Import Ban a Fatal Blow to Altria?

Home Depot

Merck

Invesco S&P 500 Equal Weight ETF

Schwab US Dividend Equity ETF

AT&T

Texas Instruments

Vanguard Total Stock Market ETF

SCHD has performed very well as investors have become less enthusiastic about the growth stocks that dominate VTI. We take an in-depth look at some of the valuation metrics and quant ratings of the top 25 stocks that make up 75% of SCHD's total value.

SCHD, RSP, Or VTI: Where To Deploy New Cash In A Correcting Market?

Its multibillion-dollar stake in Anheuser-Busch InBev unlocks on Oct. 10 and there are potential financial implications.

Altria Has a Big Decision Coming Up

Amyris

MGM Resorts

Penn Entertainment

Scotts Miracle-Gro

Smith & Wesson Brands

UBS Group AG

Sin stocks are considered defensive and tend to remain more stable under tough economic conditions. Here are the top ones to watch in 2021.

7 Sin Stocks to Buy as the World Goes to Hell in a Handbasket

The U.S. International Trade Commission barred Altria Group and Philip Morris International from importing certain tobacco products into the U.S.

News for Altria Stock (MO)